Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1792449
PUBLISHER: IMARC | PRODUCT CODE: 1792449
North America Travel Vaccines Market Report by Composition, Disease, and Country 2025-2033
PUBLISHED:
PAGES: 123 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The North America travel vaccines market size reached USD 2.01 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.24 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033.
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
- Key Regions Analysed
- United States
- Canada
- Mexico
- Analysis for Each Country
- Market by Composition
- Mono Vaccines
- Combination Vaccines
- Market by Disease
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
- Value Chain Analysis
- Key Drivers and Challenges
- Porters Five Forces Analysis
- PESTEL Analysis
- Government Regulations
- Competitive Landscape
- Competitive Structure
- Key Player Profiles
Key Questions Answered in This Report
- 1.What was the size of the North America travel vaccines market in 2024?
- 2.What is the expected growth rate of the North America travel vaccines market during 2025-2033?
- 3.What are the key factors driving the North America travel vaccines market?
- 4.What has been the impact of COVID-19 on the North America travel vaccines market?
- 5.What is the breakup of the North America travel vaccines market based on the composition?
- 6.What is the breakup of the North America travel vaccines market based on the disease?
- 7.What are the key regions in the North America travel vaccines market?
Product Code: SR112025A1717
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Travel Vaccines Market
- 5.1 Market Performance
- 5.2 Market Breakup by Composition
- 5.3 Market Breakup by Disease
- 5.4 Market Breakup by Region
- 5.5 Market Forecast
6 North America Travel Vaccines Market
- 6.1 Market Performance
- 6.2 Impact of COVID-19
- 6.3 Market Forecast
7 North America Travel Vaccines Market: Breakup by Composition
- 7.1 Mono Vaccines
- 7.2 Combination Vaccines
8 North America Travel Vaccines Market: Breakup by Disease
- 8.1 Hepatitis A
- 8.2 DPT
- 8.3 Yellow Fever
- 8.4 Typhoid
- 8.5 Hepatitis B
- 8.6 Measles and Mumps
- 8.7 Rabies
- 8.8 Meningococcal
- 8.9 Varicella
- 8.10 Japanese Encephalitis
- 8.11 Others
9 North America Travel Vaccines Market: Breakup by Country
- 9.1 United States
- 9.1.1 Historical Market Trends
- 9.1.2 Market Breakup by Composition
- 9.1.3 Market Breakup by Disease
- 9.1.4 Market Forecast
- 9.2 Canada
- 9.2.1 Historical Market Trends
- 9.2.2 Market Breakup by Composition
- 9.2.3 Market Breakup by Disease
- 9.2.4 Market Forecast
- 9.3 Mexico
- 9.3.1 Historical Market Trends
- 9.3.2 Market Breakup by Composition
- 9.3.3 Market Breakup by Disease
- 9.3.4 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
- 11.1 Overview
- 11.2 Exploratory Stage
- 11.3 Preclinical and Clinical Development
- 11.4 Regulatory Approval
- 11.5 Manufacturing
- 11.6 Marketing and Distribution
12 Porter's Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Rivalry
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
Product Code: SR112025A1717
List of Figures
- Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion USD), 2019-2024
- Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2024
- Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2024
- Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2024
- Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion USD), 2025-2033
- Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion USD), 2019-2024
- Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion USD), 2025-2033
- Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2024
- Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2024
- Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million USD), 2019 & 2024
- Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2024
- Figure 38: United States: Travel Vaccines Market: Value Trends (in Million USD), 2019-2024
- Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2024
- Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2024
- Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million USD), 2019-2024
- Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2024
- Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2024
- Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million USD), 2019-2024
- Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2024
- Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2024
- Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million USD), 2025-2033
- Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
- Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
- Figure 52: North America: Travel Vaccines Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2024 and 2033
- Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million USD), 2025-2033
- Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million USD), 2025-2033
- Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million USD), 2025-2033
- Table 5: North America: Travel Vaccines Market: Competitive Structure
- Table 6: North America: Travel Vaccines Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.